COVID-19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal
Article
[키워드] abdominal pain
ACE2
acute respiratory syndrome
addition
association
Autoimmune
bowel
Care
caused
coronavirus
coronavirus disease
COVID-19
COVID-19 epidemic
diarrhea
disease
downregulated
enzyme
Epidemic
etiology
exacerbate
expressed
feasibility
Genetic
IBD
IL-17
Imbalance
immune activation
immunosuppressive drug
increase
induce
Infection
Inflammatory
Inflammatory bowel disease
inflammatory disease
Inflammatory response
intestinal
intestinal inflammation
intestine
lung
mechanism
nonspecific
overlapping
pathway
Patient
patients
Pneumonia
progression
protective factor
receptor
Research
respiratory inflammation
risk
risk of COVID-19
SARS-CoV-2
SARS-COV-2 infection
Symptom
systemic symptom
the cytokine storm
the SARS-CoV-2
Treatment
upregulated
vaccination
[DOI] 10.1002/jmv.28067 PMC 바로가기
[DOI] 10.1002/jmv.28067 PMC 바로가기